ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2352

RORγt Expressing Foxp3+ Regulatory T Cells Regulates the Development of Autoimmune Arthritis in Mice

Yuya Kondo1, Masahiro Tahara1, Mana Iizuka1, Masahiro Yokosawa1, Shunta Kaneko1, Hiroto Tsuboi1, Satoru Takahashi2, Isao Matsumoto3 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Laboratory Animal Resource Center, University of Tsukuba, Tsukuba, Japan, 3Department of Interenal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Arthritis, regulatory cells and transcription factor, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: To determine the effect of RORγt overexpression in T cells on the development of collagen induced arthritis (CIA).

Methods: Arthritis was induced with chicken type II collagen (CII) in both C57BL/6 (B6) and CD2 T cell-specific RORγt Transgenic (RORγt Tg) mice.  Anti-CII antibody in sera was measured by ELISA. At 10 days after the first immunization of CII, lymph node (LN) cells were cultured with or without CII, and then the expression level of cytokine, transcription factor and chemokine receptor on CD4+ T cells were analyzed by flow cytometer and RT-PCR.  Cytokine levels in culture supernatants were measured by ELISA. Joint infiltrating cells were also examined by flow cytometer. Cytokine production and suppressive function of Foxp3+ regulatory T cells was analyzed in vitro. Total draining lymph nodes cells or CD4+cells were harvested from B6 mice or RORγt Tg mice at 10 days after the first immunization of CII, and cells were injected into B6 mice intravenously at 10 days after the immunization of CII.  Mice were also immunized with CII in CFA intradermally on 11 days after the cell transfer.

Results: CIA was significantly suppressed in RORγt Tg mice compared with B6 mice. Anti-CII antibody in sera was also reduced in RORγt Tg mice. RORγt expression and IL-17 production in CII reactive CD4+ T cells was significantly increased in RORγt Tg mice. Although there was no difference in IFNγ production and T-bet and Foxp3 expression between B6 mice and RORγt Tg mice, RORγt expression in Foxp3+ regulatory T cells were significantly higher in RORγt Tg mice than B6 mice. Most of Foxp3+ regulatory T cells expressed chemokine receptor 6, and which highly infiltrated in joints after the induction of CIA in RORγt Tg mice. Moreover, Foxp3+ regulatory T cells in RORγt Tg mice retain the expression of CD25, the suppressive function of effector CD4+ T cells in vitro, and IL-10 production as well as Foxp3+ regulatory T cells in B6 mice. In adoptive transfer of draining LN cells or CD4+cells from immunized mice, arthritis was significantly attenuated in recipient B6 mice transferred with cells from RORγt Tg mice. 

Conclusion: CIA was significantly suppressed in RORγt Tg mice, although IL-17 production and RORγt expression in CII reactive T cells was markedly higher than that of B6 mice. In vitro analyses and cell transfer experiments proposed the possibility that RORγt induced expression of CCR6 in Foxp3+ regulatory T cells, and these cells might regulate the development of CIA.


Disclosure:

Y. Kondo,
None;

M. Tahara,
None;

M. Iizuka,
None;

M. Yokosawa,
None;

S. Kaneko,
None;

H. Tsuboi,
None;

S. Takahashi,
None;

I. Matsumoto,
None;

T. Sumida,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ror%ce%b3t-expressing-foxp3-regulatory-t-cells-regulates-the-development-of-autoimmune-arthritis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology